Back
Nippon Telegraph & Telephone Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
61
NTTYY
Nippon Telegraph & Telephone
Last Price:
25.95
Seasonality Move:
-3.34%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
39.81
Seasonality Move:
-5.11%
Buy
61
Nippon Telegraph & Telephone (NTTYY)
is a Buy
Is Nippon Telegraph & Telephone a Buy, Sell or Hold?
- The current Nippon Telegraph & Telephone [NTTYY] share price is $25.72. The Score for NTTYY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- NTTYY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $38.88. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTTYY Stock Price Chart
What is Nippon Telegraph & Telephone's stock price today?
-
The Nippon Telegraph & Telephone share price today is $25.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTTYY is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $38.88
The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
NTTYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 63.91 | Buy |
| Chaikin Money Flow: | -35775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.63 - 25.35) | Buy |
| Bollinger Bands (100): | (24.02 - 29.06) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 50.1 | Buy |
| Chaikin Money Flow: | 536240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.59 - 39.97) | Buy |
| Bollinger Bands (100): | (38.43 - 54.53) | Sell |
NTTYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.44 | Buy |
| 20-day SMA: | 24.79 | Buy |
| 50-day SMA: | 24.33 | Buy |
| 200-day SMA: | 28.24 | Sell |
| 8-day EMA: | 25.43 | Buy |
| 20-day EMA: | 24.95 | Buy |
| 50-day EMA: | 25.05 | Buy |
| 200-day EMA: | 27.35 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.35 | Buy |
| 20-day SMA: | 38 | Buy |
| 50-day SMA: | 39.79 | Sell |
| 200-day SMA: | 52.12 | Sell |
| 8-day EMA: | 38.1 | Buy |
| 20-day EMA: | 38.47 | Buy |
| 50-day EMA: | 40.79 | Sell |
| 200-day EMA: | 49.63 | Sell |
Nippon Telegraph & Telephone Earnings Growth & NTTYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.27 per share, an increase this year of $3.51 per share, and an increase next year of $1.98 per share.
Nippon Telegraph & Telephone Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||